TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31035391

Group type: EXPERIMENTAL
Intervention: High RF‐EMF (2 W/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low RF‐EMF (1 W/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 36
Study: 28812448

Group type: COMPARATOR
Intervention: Control condition of an ongoing cluster-randomised controlled trial
Number of subjects: 20
Study: 27115063

Group type: EXPERIMENTAL
Intervention: Fortified bread (FP; 50 g bread fortified with 25 μg vitamin D3 plus placebo daily; n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Supplement (SP; 50 g plain bread plus 25 μg vitamin D supplement daily; n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (CP; 50 g plain bread plus placebo daily; n = 30)
Number of subjects: 90
Study: 24650128

Group type: EXPERIMENTAL
Intervention: High fibre supplement (HFS)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: High fibre diet (HFD)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 22155490

Group type: EXPERIMENTAL
Intervention: Heavy lunch (922 cal)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Light lunch (305 cal)
Number of subjects: 12
Study: 20300966

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) procedure
Number of subjects: 2000
Study: 19192435

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (37.5 mg/day - 300 mg/day, N = 340)
Number of subjects: 687

Group type: COMPARATOR
Intervention: Placebo (N = 347)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER
Number of subjects: 687
Study: 15862926

Group type: EXPERIMENTAL
Intervention: Intravenous sodium-lactate infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous saline infusion
Number of subjects: 0
Study: 12162507

Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: FokI polymorphism
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: BsmI polymorphism
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Genotype (FF and BB)
Number of subjects: 429
Study: 10337463

Group type: EXPERIMENTAL
Intervention: Anti-IFN alpha vaccine
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242

Group type: COMPARATOR
Intervention: Non-responder vaccinees
Number of subjects: 242
Study: 8563585

Group type: EXPERIMENTAL
Intervention: Anisterplase 30 units given intravenously before hospitalisation
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Anisterplase 30 units given intravenously later in hospital
Number of subjects: 311
Study: 1681913

Group type: EXPERIMENTAL
Intervention: Impermeable nonwoven drapes with self‐adhesive edges
Number of subjects: 61

Group type: COMPARATOR
Intervention: Permeable linen drapes sealed to the skin with self‐adhesive nonwoven tape
Number of subjects: 61
Study: 6358329

Group type: EXPERIMENTAL
Intervention: META (15 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ATR (2 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ISO (125 micrograms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 0
Study: 31523872

Group type: EXPERIMENTAL
Intervention: Baseline survey
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Follow-up survey (mean = 3.6 days post-baseline)
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: All drugs measured
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Baseline drug use
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Survey location (outside of festivals vs nightclubs)
Number of subjects: 933
Study: 28245970

Group type: EXPERIMENTAL
Intervention: rAAV.sFlt‐1 subretinal injection (low-dose: 1 × 10^10 vector genomes; high-dose: 1 × 10^11 vector genomes)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab
Number of subjects: 8
Study: 26077862

Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery (PS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Drilling
Number of subjects: 38
Study: 24714414

Group type: EXPERIMENTAL
Intervention: H.P. Acthar(®) Gel (40 or 80 IU subcutaneously twice weekly)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: H.P. Acthar(®) Gel
Number of subjects: 20
Study: 21540583

Group type: EXPERIMENTAL
Intervention: Low-dose PUFAs, polyphenols and L-carnitine (PPC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low-fat yoghurt (Control)
Number of subjects: 22
Study: 19843790

Group type: EXPERIMENTAL
Intervention: PEEP 10 group
Number of subjects: 66

Group type: COMPARATOR
Intervention: PEEP 5 group
Number of subjects: 66

Group type: COMPARATOR
Intervention: ZEEP group
Number of subjects: 66
Study: 17259872

Group type: EXPERIMENTAL
Intervention: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 1 at ages 6 and 12 months
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 2 at ages 12 and 18 months
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 3 at ages 15 and 21 months
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 1 (6 and 12 months) vs group 3 (15 and 21 months)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Routine vaccinations administered during infancy
Number of subjects: 248
Study: 15539847

Group type: EXPERIMENTAL
Intervention: Gyrus Plasmasect TURP
Number of subjects: 117

Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 117
Study: 11449083

Group type: EXPERIMENTAL
Intervention: 28.5 mg/day of isoflavones
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 57 mg/day of isoflavones
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 85.5 mg/day of isoflavones
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All doses of isoflavones
Number of subjects: 46
Study: 9684075

Group type: EXPERIMENTAL
Intervention: Preoperative drops of commercially available combination tobramycin-dexamethasone drops at 15 minute intervals
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Collagen shield soaked in tobramycin-dexamethasone
Number of subjects: 32
Study: 8030449

Group type: EXPERIMENTAL
Intervention: Combined hormonal oral contraceptive containing 75 μg gestodene plus 30 μg ethinyl estradiol
Number of subjects: 69
Study: 2977262

Group type: EXPERIMENTAL
Intervention: 0.9 mg Zoladex depot subcutaneous injection every 28 days for 12 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.8 mg Zoladex depot subcutaneous injection every 28 days for 12 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3.6 mg Zoladex depot subcutaneous injection every 28 days for 12 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Zoladex treatment (all doses)
Number of subjects: 90
Study: 31091612

Group type: EXPERIMENTAL
Intervention: Intervention group (salt reduction activities for 8 months)
Number of subjects: 2724

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2724
Study: 28989150

Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg, 5 mL) during general anesthesia induction, post-operative day 1 and day 2
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (5 mL) at corresponding time points
Number of subjects: 40
Study: 27101674

Group type: EXPERIMENTAL
Intervention: Montelukast sodium tablets combined with budesonide nasal spray and desloratadine citrate disodium tablets for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Budensonide nasal spray and desloratadine citrate disodium tablets for 4 weeks
Number of subjects: 70
Study: 23563958

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 150 mg/m(2)
Number of subjects: 186

Group type: COMPARATOR
Intervention: nab-paclitaxel 100 mg/m(2)
Number of subjects: 186
Study: 21440700

Group type: EXPERIMENTAL
Intervention: Constraint‐induced movement therapy (CIMT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bimanual training
Number of subjects: 64
Study: 20088415

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbal decoction plus western medicine (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Western medicine (Group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbal decoction (Group C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Western medicine alone (Group D)
Number of subjects: 80
Study: 16681469

Group type: EXPERIMENTAL
Intervention: Erectile Dysfunction (ED) patients
Number of subjects: 69

Group type: COMPARATOR
Intervention: Moderate ED
Number of subjects: 69
Study: 14749231

Group type: EXPERIMENTAL
Intervention: ALA + LA supplementation (2.8 g ALA + 9.0 g LA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: LA supplementation (10.9 g LA)
Number of subjects: 58
Study: 11689273

Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg per day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Troglitazone (pooled group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 9451517

Group type: EXPERIMENTAL
Intervention: 100 micrograms intravaginal misoprostol
Number of subjects: 65

Group type: COMPARATOR
Intervention: 0.5 mg intracervical gel of dinoprostone
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 65
Study: 8198235

Group type: EXPERIMENTAL
Intervention: Immunotherapy with alginate-conjugated extract of Parietaria judaica
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 3127432

Group type: EXPERIMENTAL
Intervention: L-deprenyl (10 and 40 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Tranylcypromine (mean dose, 16 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: L-deprenyl
Number of subjects: 17
Study: 30773796

Group type: EXPERIMENTAL
Intervention: Targeted intracoronary thrombolysis (pro‐urokinase and anisodamine via catheter)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Thrombus aspiration (TA)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Targeted intracoronary thrombolysis (TCA)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both TCA and TA
Number of subjects: 39
Study: 30096952

Group type: EXPERIMENTAL
Intervention: L. paracasei KW3110-containing supplements for eight weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 26813755

Group type: EXPERIMENTAL
Intervention: Mechanical traction combined with extension-oriented exercises
Number of subjects: 120

Group type: COMPARATOR
Intervention: Extension-oriented exercises alone
Number of subjects: 120
Study: 24261771

Group type: EXPERIMENTAL
Intervention: Celecoxib (100 mg/dose, twice daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Loxoprofen (60 mg/dose, 3 times daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 70

Group type: COMPARATOR
Intervention: Loxoprofen
Number of subjects: 70
Study: 21953376

Group type: EXPERIMENTAL
Intervention: 1.6 g CMC-001 (manganese-based contrast agent)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadobenate dimeglumine (intravenous contrast agent)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CMC-001 (manganese-based contrast agent)
Number of subjects: 20

Group type: COMPARATOR
Intervention: gadobenate dimeglumine (intravenous contrast agent)
Number of subjects: 20
Study: 20633071

Group type: EXPERIMENTAL
Intervention: Essential oil antiseptic mouthrinse (EOM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 22
Study: 17155972

Group type: EXPERIMENTAL
Intervention: Apical periprostatic block with 5 mL of 1% lidocaine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Basal periprostatic block with 5 mL of 1% lidocaine
Number of subjects: 143
Study: 15883575

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Program (CDSMP)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 109
Study: 15002499

Group type: EXPERIMENTAL
Intervention: Head out of water immersion (HOI) at two different temperatures in sitting position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Head out of water immersion (HOI) at two different temperatures in standing position
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microgravity during parabolic flight
Number of subjects: 0
Study: 10401901

Group type: EXPERIMENTAL
Intervention: Morphine patient-controlled analgesia with ketorolac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine patient-controlled analgesia without ketorolac (placebo)
Number of subjects: 0
Study: 7726582

Group type: EXPERIMENTAL
Intervention: Broad-spectrum sunscreen (SPF 17)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 113
Study: 2365458

Group type: EXPERIMENTAL
Intervention: Leish vaccine 5 or Leish vaccine 6 with or without Corynebacterium parvum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leish vaccine 5
Number of subjects: 0
Study: 94089

Group type: EXPERIMENTAL
Intervention: RAI treatment while on antithyroid drugs after attainment of euthyroidism
Number of subjects: 24

Group type: COMPARATOR
Intervention: No antithyroid drugs before or when RAI was given
Number of subjects: 24
Study: 31868311

Group type: EXPERIMENTAL
Intervention: Medium toothbrush group (n = 34)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Soft toothbrush group (n = 38)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 29215909

Group type: EXPERIMENTAL
Intervention: Organizational intervention designed to increase supervisor social support and job control
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 420
Study: 28387919

Group type: EXPERIMENTAL
Intervention: CRT-D with intensive drugs
Number of subjects: 124

Group type: COMPARATOR
Intervention: Intensive drugs (Control)
Number of subjects: 124
Study: 26335438

Group type: EXPERIMENTAL
Intervention: Mental Contrasting and Implementation Intentions (MCII)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Equal contact goal intention control condition (informative text about physical activity)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: MCII
Number of subjects: 36

Group type: COMPARATOR
Intervention: Equal contact goal intention control condition
Number of subjects: 36
Study: 25142565

Group type: EXPERIMENTAL
Intervention: Sonomat
Number of subjects: 62

Group type: COMPARATOR
Intervention: PSG
Number of subjects: 62
Study: 22383739

Group type: COMPARATOR
Intervention: Cisplatin (CIS)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Cisplatin plus tirapazamine (TPZ/CIS)
Number of subjects: 498
Study: 19561548

Group type: EXPERIMENTAL
Intervention: Prebiotic mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17804329

Group type: EXPERIMENTAL
Intervention: gutta percha with AH Plus (Dentsply, DeTrey, Germany)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: gutta percha with Kerr EWT (Kerr Corp, Romulus, MI)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Activ GP (Brasseler) obturation system
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Resilon (Pentron Clinical Technologies, Wallingford, CT) and Epiphany (Pentron)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EndoREZ obturation system (Ultradent, South Jordan, UT)
Number of subjects: 25
Study: 15090740

Group type: EXPERIMENTAL
Intervention: UFT (400 mg/day for 2 years)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no UFT treatment)
Number of subjects: 30
Study: 11419108

Group type: EXPERIMENTAL
Intervention: New antihypertensive drugs (angiotensin-converting enzyme inhibitors, calcium-antagonists, alpha-blockers)
Number of subjects: 58000

Group type: COMPARATOR
Intervention: Old antihypertensive drugs (thiazide diuretics, beta-blockers)
Number of subjects: 58000
Study: 9526938

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.2 microg/kg/min
Number of subjects: 107

Group type: COMPARATOR
Intervention: Propofol 100 microg/kg/min
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 107

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 107
Study: 8017151

Group type: EXPERIMENTAL
Intervention: Device 1
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Device 2
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Device 3
Number of subjects: 72
Study: 1913037

Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound (including vein stenosis)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound (normal results)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Contrast venography
Number of subjects: 19
Study: 97779

Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Single morning dose of Loperamide
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Second bedtime dose of Loperamide
Number of subjects: 47
Study: 31162002

Group type: EXPERIMENTAL
Intervention: Bespoke smoking cessation intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual smoking cessation services
Number of subjects: 22
Study: 27884071

Group type: EXPERIMENTAL
Intervention: UCAN (online Theory of Planned Behaviour-based PA behaviour change programme)
Number of subjects: 95
Study: 25415314

Group type: EXPERIMENTAL
Intervention: Pig model
Number of subjects: 50
Study: 23807564

Group type: EXPERIMENTAL
Intervention: Repaglinide alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Repaglinide with flucloxacillin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Flucloxacillin
Number of subjects: 24
Study: 21440713

Group type: EXPERIMENTAL
Intervention: High-power pain threshold ultrasound (HPPTUS) therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Local anesthetic injection (TrP)
Number of subjects: 49
Study: 20048767

Group type: EXPERIMENTAL
Intervention: Emotional slides
Number of subjects: 0
Study: 18073467

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels in patients aged <60 years
Number of subjects: 23272

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels in patients aged <60 years with below median normal glucose levels
Number of subjects: 23272

Group type: COMPARATOR
Intervention: Fibrinogen levels in individuals with impaired glucose tolerance or diabetes
Number of subjects: 23272
Study: 14760960

Group type: EXPERIMENTAL
Intervention: IVMP-IVIg
Number of subjects: 19

Group type: COMPARATOR
Intervention: IVMP
Number of subjects: 19
Study: 11677455

Group type: EXPERIMENTAL
Intervention: Sonography (US) in HIV+ children
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sonography (US) in HIV- children (control group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Comparison of US exams before and after HAART
Number of subjects: 22
Study: 9648120

Group type: EXPERIMENTAL
Intervention: Short Portable Mental Status Questionnaire
Number of subjects: 292

Group type: COMPARATOR
Intervention: Caregiver information about daily activities and performance ability
Number of subjects: 292
Study: 8205407

Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 53

Group type: COMPARATOR
Intervention: Omnivorous diet
Number of subjects: 53
Study: 2610619

Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 30s rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 120s rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 300s rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% MVC clenching
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Post-contraction blood flow
Number of subjects: 10
Study: 1092725

Group type: EXPERIMENTAL
Intervention: Stelazine (STEL) 50 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loxapine (LOX) 100 mg/day for four weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study: 11317476

Group type: EXPERIMENTAL
Intervention: Tegaserod 2 mg b.i.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tegaserod 12 mg b.i.d.
Number of subjects: 18
Study: 30247939

Group type: EXPERIMENTAL
Intervention: Sleep Well, Think Well (SWTW) group intervention
Number of subjects: 35

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 35
Study: 30268163

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen mixture plus conventional pain treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oxygen plus conventional pain treatment
Number of subjects: 90
Study: 26753892

Group type: EXPERIMENTAL
Intervention: Imipramine 25 mg once daily for 8 weeks
Number of subjects: 83
Study: 24318743

Group type: EXPERIMENTAL
Intervention: Oral phenoxodiol (PXD) plus AUC2-carboplatin
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo plus AUC2-carboplatin
Number of subjects: 142
Study: 22229304

Group type: EXPERIMENTAL
Intervention: Two portions of salmon per week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (habitual diet low in oily fish)
Number of subjects: 0
Study: 20186996

Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal laparoscopic repair (TEP)
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Open repair by the Lichtenstein procedure
Number of subjects: 1370
Study: 17505730

Group type: EXPERIMENTAL
Intervention: Reading
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise combined with reading
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (G5 - not sustaining arterial hypertension and not suffering from glaucoma or ocular hypertension)
Number of subjects: 40
Study: 15737962

Group type: EXPERIMENTAL
Intervention: Cypher stent
Number of subjects: 500
Study: 12399193

Group type: EXPERIMENTAL
Intervention: 10 micro g MPL
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 50 micro g MPL/AlPO(4)
Number of subjects: 129

Group type: COMPARATOR
Intervention: MPL-containing vaccine
Number of subjects: 129
Study: 9794569

Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10 mg once daily)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (10‐40 mg twice daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 27